Career Development and Mentoring in Clinical/Translational Alcohol Research
临床/转化酒精研究的职业发展和指导
基本信息
- 批准号:8509462
- 负责人:
- 金额:$ 21.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-06-05 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:Alcohol dependenceAlcoholic Liver DiseasesAlcoholsAmericanAreaAssociation of American Medical CollegesAwardBasic ScienceBiologicalBiological MarkersBiologyBiomedical ResearchBrainBrain imagingClinicalClinical ResearchClinical TrialsCollaborationsConsultationsCore FacilityDevelopmentDiagnostic testsDiffusionDiseaseEducational StatusEnsureEpigenetic ProcessFacultyFibrosisFunctional Magnetic Resonance ImagingFundingFutureGeneticGenomicsGlycoproteinsGrantHumanImageIndividual DifferencesInstructionInternal MedicineInternationalKnowledgeLeadershipLearningLiverMagnetic Resonance SpectroscopyMeasurementMedical StudentsMedicineMentorsMentorshipNational Institute on Alcohol Abuse and AlcoholismNeurosciencesPathologyPatientsPeer ReviewPharmacogenomicsPharmacological TreatmentPhysiciansPopulationPositioning AttributePostdoctoral FellowProductivityProteomicsPsychiatryPsychologyPublicationsReadingResearchResearch InfrastructureResearch PersonnelResearch TrainingResourcesScienceScientistSecureSeminalSenior ScientistSenior Scientist AwardSerumSocietiesStructureTechniquesTechnologyTimeTrainingTraining ProgramsTransferrinTranslational ResearchUnited States National Institutes of HealthVariantWorkaddictionalcohol abuse therapyalcohol effectalcohol researchalcohol responsebasebioimagingcareercareer developmentcostcravingdisease diagnosisdrinkingeffective therapyexperiencemedical specialtiesmeetingsneuroimagingnext generationpublic health relevanceresponsible research conductskillsstatisticssuccesstooltreatment response
项目摘要
DESCRIPTION (provided by applicant): The Senior Scientist Research and Mentorship Award is targeted for "outstanding senior scientists who have demonstrated a sustained level of high productivity conducting biomedical research" in order to protect their time to continue research while mentoring the "next generation" of investigators. With more than 25 years of experience in clinical alcohol research (over 20 clinical trials, seminal work in craving (OCDS), biomarkers of drinking (CDT), neuroimaging, and more recently in genetic and pharmacogenomics), over 15 years of continued R01 funding, 16 years of being a Scientific Director of an Alcohol Research Center, with 245 peer reviewed publications, and international recognition, the candidate meets and exceeds the requirements as an outstanding senior scientist. He has been elected to high leadership positions of leading academic/research societies, a previous leader of the COMBINE Study, and is sought out as a mentor for his expertise in bridging the gap between basic and clinical research. He has accomplished this while maintaining an active training program in alcohol research, including 20 years as Director or Co-Director of an NIAAA-sponsored T32 Research Training Grant. He has personally mentored 34 professionals (23 MDs and 11 PhDs), 20 of those in the past 4 years. Many have secured career development and independent alcohol research funding and remain tied to the alcohol field. His understanding of both the mechanisms of, and applications to, the treatment of alcohol disorders is atypical and rare. This award is important to the candidate for two major reasons. First, it will provide him with protected time to keep his alcohol research career on the cutting edge by enabling him to continue formal and informal training in genetics (e.g. epigenetics), proteomics (e.g. glycoproteomics), and new/advanced neuroimaging skills (fMRI connectivity analysis, diffusion kurtosis, and H1-magnetic resonance spectroscopy), apply these essential areas of science to his own alcohol research (as outlined), and communicate new discoveries to the alcohol treatment field in general. Second, this award will provide the candidate with protected time from additional clinical and administrative duties to apply his vast experience and newly acquired skills to his mentoring activities and the development of younger clinical- scientists. With the NIH and the American Association of Medical Colleges highlighting the large, unmet need in the U.S. for clinical and translational researchers (especially in the area of genomics) and with millions of Americans suffering from alcohol disorders, who are underserved and who cost the US economy over $200 billion each year, there is a need to push clinical research forward, a need to ensure our senior scientists are on the cutting edge in their own research, and a need to train future scientists to carry on this research to find effective treatments. This K05 Senior Scientist Career and Mentoring Award will allow this to happen.
描述(由申请人提供):高级科学家研究和指导奖旨在奖励“在生物医学研究中表现出持续高生产力水平的杰出高级科学家”,以保护他们继续研究的时间,同时指导“下一代”的调查员。拥有超过 25 年的临床酒精研究经验(超过 20 项临床试验、酒瘾研究 (OCDS)、饮酒生物标志物 (CDT)、神经影像学以及最近在遗传和药物基因组学方面的开创性工作),超过 15 年的持续 R01 资助担任酒精研究中心科学主任 16 年,发表过 245 篇同行评审出版物,并获得国际认可,该候选人满足并超过了作为杰出高级科学家的要求。他曾被选为领先学术/研究协会的高级领导职务,曾担任 COMBINE 研究的领导者,并因其在弥合基础研究和临床研究之间差距方面的专业知识而被视为导师。他在实现这一目标的同时,还积极开展酒精研究方面的培训计划,其中包括担任 NIAAA 资助的 T32 研究培训基金的主任或联合主任 20 年。他亲自指导了 34 名专业人士(23 名医学博士和 11 名博士),其中 20 名是在过去 4 年中培养的。许多人已经获得了职业发展和独立酒精研究资金,并仍然与酒精领域保持联系。他对酒精障碍治疗机制和应用的理解是非典型且罕见的。该奖项对候选人来说很重要,主要有两个原因。首先,这将为他提供受保护的时间,使他能够继续在遗传学(例如表观遗传学)、蛋白质组学(例如糖蛋白质组学)和新的/先进的神经影像技能(功能磁共振成像连接)方面进行正式和非正式的培训,从而使他的酒精研究事业保持在最前沿。分析、扩散峰度和 H1 磁共振波谱),将这些重要的科学领域应用到他自己的酒精研究中(如概述),并将新发现传达给整个酒精治疗领域。其次,该奖项将为候选人提供受保护的时间,使其免于额外的临床和行政职责,将其丰富的经验和新获得的技能应用于指导活动和年轻临床科学家的发展。美国国立卫生研究院和美国医学院协会强调,美国对临床和转化研究人员(特别是在基因组学领域)存在巨大且未得到满足的需求,并且数百万美国人患有酒精障碍,他们得不到充分的服务,并付出了高昂的代价每年经济超过2000亿美元,需要推动临床研究向前发展,需要确保我们的资深科学家在自己的研究中处于前沿,并且需要培训未来的科学家进行这项研究以找到有效的治疗方法。 K05 高级科学家职业和指导奖将使这一切成为可能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RAYMOND F ANTON其他文献
RAYMOND F ANTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RAYMOND F ANTON', 18)}}的其他基金
Gabapentin for Relapse Prevention: Alc. Withdrawal-Brain GABA/Glutamate Effects
加巴喷丁预防复发:Alc。
- 批准号:
9108808 - 财政年份:2014
- 资助金额:
$ 21.62万 - 项目类别:
Gabapentin for Relapse Prevention: Alc. Withdrawal-Brain GABA/Glutamate Effects
加巴喷丁预防复发:Alc。
- 批准号:
9315600 - 财政年份:2014
- 资助金额:
$ 21.62万 - 项目类别:
Gabapentin for Relapse Prevention: Alc. Withdrawal-Brain GABA/Glutamate Effects
加巴喷丁预防复发:Alc。
- 批准号:
8696333 - 财政年份:2014
- 资助金额:
$ 21.62万 - 项目类别:
Evaluating the Genetic Variability of Naltrexone Response
评估纳曲酮反应的遗传变异性
- 批准号:
7754444 - 财政年份:2009
- 资助金额:
$ 21.62万 - 项目类别:
Genetic and brain mechanisms of naltrexone's treatment efficacy for alcoholism
纳曲酮治疗酒精中毒疗效的遗传和脑机制
- 批准号:
8912020 - 财政年份:2009
- 资助金额:
$ 21.62万 - 项目类别:
Genetic and brain mechanisms of naltrexone's treatment efficacy for alcoholism
纳曲酮治疗酒精中毒疗效的遗传和脑机制
- 批准号:
7840483 - 财政年份:2009
- 资助金额:
$ 21.62万 - 项目类别:
Genetic and brain mechanisms of naltrexone's treatment efficacy for alcoholism
纳曲酮治疗酒精中毒疗效的遗传和脑机制
- 批准号:
8461700 - 财政年份:2009
- 资助金额:
$ 21.62万 - 项目类别:
Genetic and brain mechanisms of naltrexone's treatment efficacy for alcoholism
纳曲酮治疗酒精中毒疗效的遗传和脑机制
- 批准号:
7647660 - 财政年份:2009
- 资助金额:
$ 21.62万 - 项目类别:
Genetic and brain mechanisms of naltrexone's treatment efficacy for alcoholism
纳曲酮治疗酒精中毒疗效的遗传和脑机制
- 批准号:
8270569 - 财政年份:2009
- 资助金额:
$ 21.62万 - 项目类别:
Genetic and brain mechanisms of naltrexone's treatment efficacy for alcoholism
纳曲酮治疗酒精中毒疗效的遗传和脑机制
- 批准号:
8069348 - 财政年份:2009
- 资助金额:
$ 21.62万 - 项目类别:
相似国自然基金
HDGF-K39位点乳酸化修饰激活糖酵解促进非酒精性脂肪性肝病相关肝癌发生的作用机制研究
- 批准号:82372616
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
AGEs-RAGE轴诱导的肝细胞衰老促进糖尿病合并非酒精性脂肪性肝病进展的机制研究
- 批准号:82300914
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
核受体NR2E1通过靶向SIRT1调控非酒精性脂肪肝病进程及机制研究
- 批准号:82300678
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MSP/RON/STAT3信号轴调控肝细胞自噬促进非酒精性脂肪性肝病进展的分子机制
- 批准号:82300668
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
从AMPK调控线粒体裂变和融合研究金钗石斛总生物碱抗非酒精性脂肪肝病的分子机制
- 批准号:82360808
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Using patient-level decision modeling to improve use of treatments for alcohol use disorder
使用患者层面的决策模型来改善酒精使用障碍治疗的使用
- 批准号:
10712474 - 财政年份:2023
- 资助金额:
$ 21.62万 - 项目类别:
Role of gut microbial ethanol production in alcohol use disorder and alcohol-associated liver disease
肠道微生物乙醇产生在酒精使用障碍和酒精相关性肝病中的作用
- 批准号:
10785985 - 财政年份:2023
- 资助金额:
$ 21.62万 - 项目类别:
Circadian rhythms and alcohol in the BMAL1 knockout rat
BMAL1 敲除大鼠的昼夜节律和酒精
- 批准号:
10451307 - 财政年份:2022
- 资助金额:
$ 21.62万 - 项目类别:
Pulmonary Disfunction after Polysubstance Exposure: Mechanistic Identification of Inflammatory Mediators
多物质暴露后的肺功能障碍:炎症介质的机制识别
- 批准号:
10334101 - 财政年份:2022
- 资助金额:
$ 21.62万 - 项目类别:
Limbic Pallidum DBS for the treatment of severe alcohol use disorder
边缘苍白球 DBS 用于治疗严重酒精使用障碍
- 批准号:
10706607 - 财政年份:2022
- 资助金额:
$ 21.62万 - 项目类别: